Abingworth as of June 30, 2020
Portfolio Holdings for Abingworth
Abingworth holds 16 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vaxcyte Common (PCVX) | 36.8 | $132M | 4.2M | 31.55 | |
| Personalis Common (PSNL) | 19.7 | $71M | 5.4M | 12.96 | |
| Phathom Common (PHAT) | 11.0 | $39M | 1.2M | 32.72 | |
| Crispr Namen Akt (CRSP) | 10.6 | $38M | 519k | 73.31 | |
| Soleno Common | 6.4 | $23M | 10M | 2.21 | |
| Exicure Common | 4.7 | $17M | 7.0M | 2.43 | |
| Sierra Oncology Common | 2.9 | $11M | 877k | 12.02 | |
| Sientra Common | 2.6 | $9.2M | 2.4M | 3.86 | |
| Paratek Common | 1.5 | $5.4M | 1.0M | 5.21 | |
| Verona Sponds Adr (VRNA) | 1.2 | $4.2M | 902k | 4.68 | |
| Protara Common (TARA) | 0.8 | $3.0M | 54k | 55.98 | |
| Molecular Templates Common | 0.8 | $2.8M | 200k | 13.79 | |
| Aeglea Common | 0.6 | $2.2M | 241k | 9.23 | |
| Obseva Common | 0.1 | $517k | 88k | 5.88 | |
| Cymabay Common | 0.1 | $456k | 131k | 3.48 | |
| Ocugen Common | 0.0 | $2.0k | 7.1k | 0.28 |
